Lonnie Bookbinder


United States
Also Known As
Founder, Chairman of the Board of Directors at ARIZ Precision Medicine

Founder and Chairman of ARIZ Precision Medicine (arizbio.com). Experienced in drug development, marketing, business and corporate development. Educational background in pharmacology, toxicology, business management, biology and genetics. Current interests in targeted drug delivery of drug payloads that attack cancer at the initiation point by modifying the activity of master regulators of the histone code. By inhibiting or modifying the activity of the histone methyl transferases, especially the PRDM genes and proteins, our goal is to stop cancer at an early stage by removing the key driver of the oncogenic process. We intend to partner with enabling companies including pharmaceutical companies. Our first products are targeted to myeloma and breast cancer as well as subsequent products will include colorectal, liver, lung and prostate cancers. https://www.bloomberg.com/press-releases/2021-03-18/cps-health-care-and-telewellness-present-the-rating-of-covid-technologies-on-a-lifetime-award

Voted (0)

Works (0)

Video (0)

News about Lonnie Bookbinder(0)

Join our Telegram Channel!